GemPharmatech Co., Ltd. (SHA:688046)
31.39
-3.11 (-9.01%)
Nov 16, 2026, 4:00 PM EST
GemPharmatech Market Cap
GemPharmatech has a market cap or net worth of 12.84 billion as of November 16, 2026. It is the 6,595th most valuable company in the world and the 1,180th biggest in China. Its market cap has increased by 70.43% in one year.
Market Cap
12.84B
Enterprise Value
11.95B
Revenue
941.80M
Global Rank
Country Rank
#1,180 China
PE Ratio
62.83
ChartMarket Cap Chart
Since April 25, 2022, GemPharmatech's market cap has increased from 7.59B to 12.84B, an increase of 69.33%. That is a compound annual growth rate of 12.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 16, 2026 | 12.84B | 103.94% |
| Dec 31, 2025 | 6.30B | 19.98% |
| Dec 31, 2024 | 5.25B | -36.47% |
| Dec 29, 2023 | 8.26B | -16.22% |
| Dec 30, 2022 | 9.86B | 30.00% |
| Apr 25, 2022 | 7.59B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Evopoint Biosciences | 15.12B |
| HitGen | 13.90B |
| Sinocelltech Group | 13.46B |
| Jinyu Bio-technology | 13.08B |
| Anhui Anke Biotechnology (Group) | 12.79B |
| Acrobiosystems | 12.75B |
| BrightGene Bio-Medical Technology | 12.14B |
| Sino Biological,Inc. | 11.18B |